SHANGHAI, Feb. 19, 2024 /PRNewswire/ AffaMed Therapeutics ("AffaMed"), a biotechnology company dedicated to developing and commercializing transformative
Nomura is starting to rebuild in Hong Kong efinancialcareers.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efinancialcareers.com Daily Mail and Mail on Sunday newspapers.
Two of Nomura’s equity capital markets bankers in Hong Kong have joined the growing exodus out of the industry.
Thomas Batt, Nomura’s of capital markets and solutions for Asia ex-Japan, has left to become CFO of Paceline in London. Paceline which has just completed a Series A fundraising, describes itself as the “first ever fitness rewards platform that adds financial benefit to your physical activity.”
It’s not known what the financial benefits are to Batt’s own physical move, but he joins an increasing number of senior bankers who are quitting banking for a more entrepreneurial challenge and the prospect of more upside than they can earn in banking. “Banking compensation will never come back to pre-global financial crisis levels. There s greater risk’/reward at a start-up and there will be more departures like this from across the street” said one source in Hong Kong
Wall Street and C-Suite grapple with a meme-stock new normal
Haters everywhere in stock market after S&P 500 s big first half
Larry Berman: Warning, the making of the Mother of all crashes
Ryan Bushell s Top Picks: June 25, 2021
Banks easily clear U.S. stress tests, setting stage for payouts
Pattie Lovett-Reid: Investors need to get realistic about return expectations
Stan Wong s Top Picks: June 24, 2021
BofA favours Canada stocks with big discount to frothy S&P 500
Stephen Takacsy s Top Picks: June 23, 2021
S&P 500 stuck in trading lull while bonds retreat
New CPPIB head says inflation will stay muted in long run